Internal Medicine Alert – October 15, 2018

October 15, 2018

• Revised Anticoagulation Therapy Guidelines for Atrial Fibrillation Patients

  More patients with atrial fibrillation may receive anticoagulation, according to new recommendations.

  Read more about Revised Anticoagulation Therapy Guidelines for Atrial Fibrillation Patients - Internal Medicine Alert – October 15, 2018

• Are In-hospital Deaths Related to Community-acquired Pneumonia Preventable?

  This secondary analysis of data from five tertiary care centers found that among patients hospitalized for community-acquired pneumonia, very few deaths potentially were related to a lapse in in-hospital quality of pneumonia care.

  Read more about Are In-hospital Deaths Related to Community-acquired Pneumonia Preventable? - Internal Medicine Alert – October 15, 2018

• Home-based Detection of Undiagnosed Atrial Fibrillation

  In patients with risk factors for atrial fibrillation, screening with a self-applied wearable ECG patch resulted in significantly increased rates of new atrial fibrillation diagnoses within four months, along with greater use of anticoagulants and healthcare resources.

  Read more about Home-based Detection of Undiagnosed Atrial Fibrillation - Internal Medicine Alert – October 15, 2018

• Eravacycline Injection (Xerava)

  The FDA has approved a new parenteral, broad-spectrum antibiotic in the tetracycline class for the treatment of complicated intra-abdominal infections.

  Read more about Eravacycline Injection (Xerava) - Internal Medicine Alert – October 15, 2018

• Biventricular Hypertrophy in an Asymptomatic Patient?

  Read more about Biventricular Hypertrophy in an Asymptomatic Patient? - Internal Medicine Alert – October 15, 2018